vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
16.26
-0.04 (-0.25%)
Jun 4, 2025, 1:42 PM - Market open
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $51.94 million as of June 4, 2025. Its market cap has decreased by -38.09% in one year.
Market Cap
51.94M
Enterprise Value
21.14M
1-Year Change
-38.09%
Ranking
Category
Stock Price
$16.26
Market Cap Chart
Since July 30, 2015, vTv Therapeutics's market cap has decreased from $357.30M to $51.94M, a decrease of -85.46%. That is a compound annual growth rate of -17.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2025 | 52.10M | 18.41% |
| Dec 31, 2024 | 44.00M | 46.18% |
| Dec 29, 2023 | 30.10M | -56.57% |
| Dec 30, 2022 | 69.30M | -22.66% |
| Dec 31, 2021 | 89.60M | -34.79% |
| Dec 31, 2020 | 137.40M | 34.97% |
| Dec 31, 2019 | 101.80M | -5.74% |
| Dec 31, 2018 | 108.00M | -45.23% |
| Dec 29, 2017 | 197.20M | 24.42% |
| Dec 30, 2016 | 158.50M | -29.08% |
| Dec 31, 2015 | 223.50M | -37.45% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.98B |
| Johnson & Johnson | 371.28B |
| AbbVie | 330.49B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 273.23B |
| Abbott Laboratories | 231.17B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |